Linked e-resources
Details
Table of Contents
Intro; Contents; 1: Introduction to Lumpy Skin Disease; 2: General Description of Lumpy Skin Disease; References; 3: Economic Impact of Lumpy Skin Disease; 3.1 Direct Impact of Clinical Disease; 3.2 Indirect Economic Impact of LSD; References; 4: Geographic Distribution of Lumpy Skin Disease; References; 5: Current Legislation and Trade Recommendations; References; Part I: Lumpy Skin Disease Virus; 6: Taxonomy; References; 7: Morphology; References; 8: Genome; References; 9: Replication in a Host; References; 10: Propagation of the Virus In Vitro; References
11: Persistence and Stability of the VirusReferences; 12: Immunity; References; 13: Epidemiology and Transmission; 13.1 Transmission Modes of LSDV; 13.2 Potential Vectors of Lumpy Skin Disease Virus; 13.3 Direct Transmission of Lumpy Skin Disease; 13.4 Transmission Via Subclinically Infected Cattle; 13.5 Spread of Lumpy Skin Disease; 13.6 Seasonality; 13.7 Geographical Risk Factors; 13.8 Risk Factors in the Herd Level; 13.9 Risk Factors in the Animal Level; 13.10 Further Suggested Studies; References; Part II: Early Detection of Lumpy Skin Disease, Diagnostic Tools and Treatment
14: Clinical SignsReferences; 15: Sample Collection and Transport; References; 16: Diagnostic Tools; References; 17: Treatment of Lumpy Skin Disease; Part III: Control and Eradication; 18: Vaccines Against LSD and Vaccination Strategies; 18.1 Vaccination Strategies; References; 19: Slaughter of Infected and In-Contact Animals; References; 20: Animal Movement Control and Quarantine; References; 21: Vector Surveillance and Control; 21.1 Vector Surveillance; 21.2 Vector Control; References; 22: Decontamination and Disinfection; References; 23: Active and Passive Surveillance; References
11: Persistence and Stability of the VirusReferences; 12: Immunity; References; 13: Epidemiology and Transmission; 13.1 Transmission Modes of LSDV; 13.2 Potential Vectors of Lumpy Skin Disease Virus; 13.3 Direct Transmission of Lumpy Skin Disease; 13.4 Transmission Via Subclinically Infected Cattle; 13.5 Spread of Lumpy Skin Disease; 13.6 Seasonality; 13.7 Geographical Risk Factors; 13.8 Risk Factors in the Herd Level; 13.9 Risk Factors in the Animal Level; 13.10 Further Suggested Studies; References; Part II: Early Detection of Lumpy Skin Disease, Diagnostic Tools and Treatment
14: Clinical SignsReferences; 15: Sample Collection and Transport; References; 16: Diagnostic Tools; References; 17: Treatment of Lumpy Skin Disease; Part III: Control and Eradication; 18: Vaccines Against LSD and Vaccination Strategies; 18.1 Vaccination Strategies; References; 19: Slaughter of Infected and In-Contact Animals; References; 20: Animal Movement Control and Quarantine; References; 21: Vector Surveillance and Control; 21.1 Vector Surveillance; 21.2 Vector Control; References; 22: Decontamination and Disinfection; References; 23: Active and Passive Surveillance; References